Foghorn Therapeutics Inc. (FHTX) Financials

FHTX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 285.9 million 363.1 million
2023-09-30 313.4 million 370.8 million
2023-06-30 339.6 million 388.9 million
2023-03-31 372.9 million 397.5 million

FHTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -27.6 million 3.1 million
2023-09-30 -27.3 million 4.1 million
2023-06-30 -32.6 million 4.5 million
2023-03-31 -31.8 million 4.6 million

FHTX Net Income

No data available :(

FHTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 234.1 million - 45.1 million
2023-09-30 259.9 million - 47.1 million
2023-06-30 284.3 million - 47.9 million
2023-03-31 316.0 million - 49.8 million

FHTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 42.3 million
2023-09-30 42.0 million
2023-06-30 41.8 million
2023-03-31 41.8 million

FHTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 37000 23.4 million 7.0 million -
2023-09-30 82000 26.3 million 8.3 million -
2023-06-30 469000 29.2 million 8.4 million -
2023-03-31 636000 30.0 million 8.6 million -

FHTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 5.8 million 852000
2023-09-30 17.5 million 864000
2023-06-30 5.6 million 2.2 million
2023-03-31 5.3 million 2.1 million

FHTX

Price: $5.90

52 week price:
2.70
9.97

Earnings Per Share: -2.34 USD

P/E Ratio: -2.42

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 18512

Market Capitalization: 306.9 million

Links: